Quantbot Technologies LP Acquires 40,962 Shares of Koninklijke Philips (NYSE:PHG)

Quantbot Technologies LP grew its holdings in shares of Koninklijke Philips (NYSE:PHG) by 237.6% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 58,202 shares of the technology company’s stock after acquiring an additional 40,962 shares during the quarter. Quantbot Technologies LP’s holdings in Koninklijke Philips were worth $1,474,000 at the end of the most recent quarter.

Other hedge funds have also recently made changes to their positions in the company. Wilmington Savings Fund Society FSB purchased a new position in Koninklijke Philips in the 3rd quarter worth $54,000. Farther Finance Advisors LLC grew its stake in shares of Koninklijke Philips by 37.1% during the fourth quarter. Farther Finance Advisors LLC now owns 2,150 shares of the technology company’s stock valued at $54,000 after buying an additional 582 shares during the last quarter. Whipplewood Advisors LLC purchased a new position in shares of Koninklijke Philips in the fourth quarter worth about $55,000. Millstone Evans Group LLC bought a new stake in shares of Koninklijke Philips in the 4th quarter valued at about $60,000. Finally, Allworth Financial LP boosted its holdings in Koninklijke Philips by 24.9% during the 4th quarter. Allworth Financial LP now owns 3,993 shares of the technology company’s stock valued at $105,000 after acquiring an additional 797 shares during the period. 13.67% of the stock is currently owned by institutional investors.

Koninklijke Philips Trading Down 0.1 %

NYSE PHG opened at $25.46 on Tuesday. The stock has a market cap of $23.93 billion, a P/E ratio of -30.31, a price-to-earnings-growth ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a fifty-two week low of $19.10 and a fifty-two week high of $32.91. The stock has a 50 day simple moving average of $26.73 and a two-hundred day simple moving average of $27.68. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.74 and a current ratio of 1.23.

Koninklijke Philips (NYSE:PHG) last released its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a negative net margin of 3.88% and a positive return on equity of 10.85%. The company had revenue of $5.38 billion during the quarter, compared to the consensus estimate of $5.10 billion. On average, analysts forecast that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The business also recently declared an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be paid a $0.886 dividend. This represents a yield of 2.9%. The ex-dividend date is Tuesday, May 13th. Koninklijke Philips’s payout ratio is currently -89.29%.

Analyst Upgrades and Downgrades

Several brokerages have weighed in on PHG. UBS Group upgraded Koninklijke Philips from a “neutral” rating to a “buy” rating in a research report on Thursday, February 20th. BNP Paribas raised shares of Koninklijke Philips from a “neutral” rating to an “outperform” rating in a research note on Tuesday, February 25th. StockNews.com raised shares of Koninklijke Philips from a “hold” rating to a “buy” rating in a research report on Saturday, March 8th. Finally, Sanford C. Bernstein upgraded shares of Koninklijke Philips from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, March 18th. Two investment analysts have rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy”.

Koninklijke Philips Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.